NorthStar Medical Radioisotopes
The MSAT II, CDMO role independently leads technical activities supporting technology transfer, process validation, scale-up, and commercial manufacturing within a CDMO environment. This position serves as a primary technical resource for manufacturing operations, investigations, process monitoring, and cross-functional project execution. The role drives process improvements, manages technical deliverables, and interfaces with sponsors and internal stakeholders to ensure successful program outcomes.
Headquarters
Beloit, Wisconsin, United States
Company Size
201-500 employees
Founded
2006
NorthStar Medical Radioisotopes is a radiopharmaceutical company that develops, manufactures, and supplies medical radioisotopes and radiopharmaceutical therapies to improve detection and treatment of cancer and other serious diseases. The company advances targeted radiotherapies and diagnostic agents—working with isotopes such as actinium‑225 and copper‑67—and provides development and CDMO/CMO manufacturing services for industry partners. NorthStar emphasizes global patient access, scientific expertise, and integrated supply‑chain capabilities to support clinical programs and commercial delivery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NorthStar Medical Radioisotopes.
NorthStar Medical Radioisotopes didn’t post a salary, so this is our estimate from similar listings.
33% above the average for this role